HCV-Specific T-Cell Response in Relation to Viral Kinetics and Treatment Outcome (DITTO-HCV Project)

Gastroenterology

Volumn 133, Issue 4, 2007, Pages 1132-1143

  Pilli, Massimo ^a   Zerbini, Alessandro ^a   Penna, Amalia ^a   Orlandini, Alessandra ^a   Lukasiewicz, Esther ^b   Pawlotsky, Jean Michel ^c   Zeuzem, Stefan ^d   Schalm, Solko W ^e   von Wagner, Michael ^d   Germanidis, Georgios ^f   Lurie, Yoav ^g   Esteban, Juan I ^h   Haagmans, Bart L ^e   Hezode, Christophe ^c   Lagging, Martin ⁱ   Negro, Francesco ^j   Homburger, Yonit ^b   Neumann, Avidan U ^b   Ferrari, Carlo ^a   Missale, Gabriele ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b BAR ILAN UNIVERSITY   (Israel)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^g TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ UNIVERSITY OF GOTHENBURG   (Sweden)

^j GENEVA UNIVERSITY HOSPITALS   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN;

ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 34848870230     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.06.059     Document Type: Article

References (25)

1. Manns M.P., McHutchison J.G., Gordon S.C., et al. Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 (2001) 958-965
2. Fried M.W., Shiffman M.L., Reddy K.R., et al. Peginterferon alpha-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347 (2002) 975-982
3. Hadziyannis S.J., Sette Jr. H., Morgan T., et al. Peginterferon alpha-2a (40 kD) and ribavirin combination therapy in chronic hepatitis C: randomized study of the effect of treatment duration and ribavirin dose. Ann Intern Med 140 (2004) 346-355
4. Neumann A.U., Lam N.P., Dahari H., et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282 (1998) 103-107
5. Zeuzem S., Herrmann E., Lee J.H., et al. Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a. Gastroenterology 120 (2001) 1438-1447
6. Perelson A.S., Herrmann E., Micol F., et al. New kinetic models for the hepatitis C virus. Hepatology 42 (2005) 749-754
7. Thomas H., Foster G., and Platis D. Mechanisms of action of interferon and nucleoside analogues. J Hepatol 39 (2003) S93-S98
8. Brinkmann V., Geiger T., Alkan S., et al. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T-cells. J Exp Med 178 (1993) 1655-1663
9. Tam R.C., Pai B., Bard J., et al. Ribavirin polarizes human T-cell responses towards a type 1 cytokine profile. J Hepatol 30 (1999) 376-382
10. Cramp M.E., Rossol S., Chokshi S., et al. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 118 (2000) 346-355
11. Kamal S.M., Fehr J., Roesler B., et al. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 123 (2002) 1070-1083
12. Barnes E., Harcourt G., Brown D., et al. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 36 (2002) 743-754
13. Kamal S.M., Ismail A., Graham C.S., et al. Pegylated interferon a therapy in acute hepatitis C: relation to hepatitis C virus-specific T-cell response kinetics. Hepatology 39 (2004) 1721-1731
14. Rahman F., Heller T., Sobao Y., et al. Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology 40 (2004) 87-97
15. Tang K.H., Herrmann E., Cooksley H., et al. Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype-1 during peginterferon and ribavirin therapy. J Hepatol 43 (2005) 776-782
16. Kaplan D.E., Sugimoto K., Ikeda F., et al. T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C. Hepatology 41 (2005) 1365-1375
17. Hultgren C., Desombere I., Leroux-Roels G., et al. Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses. J Hepatol 40 (2004) 971-978
18. Zeuzem S., Pawlotsky J.M., Lukasiewicz E., et al., DITTO-HCV Study Group. International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C. J Hepatol 43 (2005) 250-257
19. Yusim K., Richardson R., Tao N., et al. The Los Alamos hepatitis C immunology database. Appl Bioinformatics 4 (2005) 217-225
20. Penna A., Chisari F.V., Bertoletti A., et al. Cytotoxic T lymphocytes recognize an HLA A2 restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 174 (1991) 1565-1570
21. Morishima C., Polyak S.J., Ray R., et al., Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group. Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C. J Infect Dis 193 (2006) 931-940
22. Missale G., Cariani E., Lamonaca V., et al. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype-1b- and genotype 2c-infected patients. Hepatology 26 (1997) 792-797
23. Lasarte J.J., Garcia-Granero M., Lopez A., et al. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. Hepatology 28 (1998) 815-822
24. Yusim K., Richardson R., Tao N., et al. The Los Alamos hepatitis C immunology database. Appl Bioinformatics 4 (2005) 217-225
25. Perelson A.S., Herrmann E., Micol F., et al. New kinetic models for the hepatitis C virus. Hepatology 42 (2005) 749-754